Value of 18F-FDG PET/CT in the diagnosis and treatment of colorectal cancer liver metastases
10.3760/cma.j.issn.2095-2848.2019.09.014
- VernacularTitle: 18F－FDG PET/CT在结直肠癌肝转移诊治中的应用价值
- Author:
Wujian MAO
1
,
2
,
3
;
Hongcheng SHI
Author Information
1. Department of Nuclear Medicine, Zhongshan Hospital, Fudan University
2. Nuclear Medicine Institute of Fudan University
3. Shanghai Institute of Medical Imaging, Shanghai 200032, China
- Publication Type:Review
- Keywords:
Colorectal neoplasms;
Neoplasm metastasis;
Liver;
Positron-emission tomography;
Tomography, X-ray computed;
Deoxyglucose
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2019;39(9):560-563
- CountryChina
- Language:Chinese
-
Abstract:
18F-fluorodeoxyglucose (FDG) PET/CT offers excellent diagnostic performance on colorectal cancer liver metastases(CRCLM) in terms of sensitivity and specificity, and can comprehensively identify the presence of extrahepatic metastases and provide valuable information for the treatment decision making. 18F-FDG PET/CT can also be used in the early assessment of response to CRCLM therapy and survival prediction. However, the diagnostic value of PET/CT is limited for lesions with diameter within 10 mm or with activity inhibited strongly by chemotherapy. PET combined with contrast enhanced CT may have potential value in improving diagnostic sensitivity for CRCLM.
